Prof. Capdevila shares his views on the potential impact of ongoing phase III studies on the guidelines for managing well-differentiated neuroendocrine tumors.

Discover how the recent advancements in theranostics have revolutionized nuclear medicine through Prof. Pubul Núñez's insightful explanation.

Prof. Grana provides an overview of the main issues and challenges currently facing PRRT and its role in managing NETs.